Comments

Crinetics Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Crinetics Pharmaceuticals (CRNX) operate in?

Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CRNXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$34.14

-1.64-4.58%

At close: -

$34.14

0.000.00%

After Hours: 4:54 PM EDT

Q4 2024 Earnings were released on Thu Feb 27th, after the market close

The most recent conference call was at 16:30 PM, 4 days ago Click to view past webcast

Crinetics Pharmaceuticals (CRNX) Forecast

News Earnings Crinetics Pharmaceuticals (CRNX) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Crinetics Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:CRNX | Benzinga

Explore Crinetics Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRNX.

Open	$35.94
Close	$34.14
Volume / Avg.	1.24M / 900.74K
Day Range	$34.10 - $36.50
52 Wk Range	31.84 - 62.53
Market Cap	$3.17B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	8.56%
Days to Cover	11.6

Recent News

This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Avi Kapoor

Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential

Neurocrine's Crenessity receives FDA approval as a groundbreaking adjunctive treatment for classic CAH, offering a novel approach to hormone regulation.

Vandana Singh

XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit Therapeutics, Plug Power and XPeng Inc.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$35.94
Close	$34.14
Volume / Avg.	1.24M / 900.74K
Day Range	$34.10 - $36.50
52 Wk Range	31.84 - 62.53
Market Cap	$3.17B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	8.56%
Days to Cover	11.6

About Crinetics Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Crinetics Pharmaceuticals (CRNX) stock?

You can purchase shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) through any online brokerage.

View our list of the best stock brokerages

Who are Crinetics Pharmaceuticals (CRNX) competitors?

Other companies in Crinetics Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and SpringWorks Therapeutics (NASDAQ:SWTX).

What is the forecast, or price target, for Crinetics Pharmaceuticals (CRNX) stock?

Crinetics Pharmaceuticals has a consensus price target of $68.47.

What is the current price for Crinetics Pharmaceuticals (CRNX)?

The stock price for Crinetics Pharmaceuticals (NASDAQ: CRNX) is $34.14 last updated March 3, 2025 at 4:54 PM EST.

Does Crinetics Pharmaceuticals (CRNX) pay a dividend?

There are no upcoming dividends for Crinetics Pharmaceuticals.

When is Crinetics Pharmaceuticals (NASDAQ:CRNX) reporting earnings?

Crinetics Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Crinetics Pharmaceuticals (CRNX) going to split?

There is no upcoming split for Crinetics Pharmaceuticals.

What sector and industry does Crinetics Pharmaceuticals (CRNX) operate in?

Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.